Wall Street’s Key Stock Analysts Research Report, All Buys

Wall Street’s Key Stock Analysts Research Report, All Buys

stocks #bullish #buys #analysts #research #WallStreet

$ATVI $ATUS $KNTE $RMR $RKT

These are all Buys if you can manage the risk.

Daily HeffX-LTN reviews dozens of Wall Street’s Key analysts research reports to ID new trading and investing ideas for HeffX-LTN readers. These reports cover stocks to buy

Below are our Buy calls for Tuesday, 29 December, as follows:

Activision Blizzard Inc. (NASDAQ:ATVI) was reiterated at Truist Securities with a Buy rating and a 90 price target. The consensus price target for the gaming giant is 97.28.

Altice USA Inc. (NYSE:ATUS) was reiterated at Raymond James with a Strong Buy rating and a 42 price target. That compares with the 38.73 consensus target and last Monday’s 36.92 closing price.

Kinnate Biopharma Inc. (NASDAQ:KNTE) was started with a Buy rating and a 48 price target at Goldman Sachs. The stock had a recent IPO and has traded between 34.14 and 48.75 since. Piper Sandler also started the company with a Buy rating but with a 60 target.

RMR Group Inc. (NASDAQ:RMR) was started with a Buy rating and a 45 price target at BTIG Research. The consensus figure is 35.71.

Rocket Companies Inc. (NYSE:RKT): this is high-tech firm that facilitates lending is the wave of the future. Shares have a consensus price target of 24.70.

Have a healthy day, Keep the Faith!

  

The following two tabs change content below.

Paul Ebeling

Paul A. Ebeling, a polymath, excels, in diverse fields of knowledge Including Pattern Recognition Analysis in Equities, Commodities and Foreign Exchange, and he is the author of "The Red Roadmaster's Technical Report on the US Major Market Indices, a highly regarded, weekly financial market commentary. He is a philosopher, issuing insights on a wide range of subjects to over a million cohorts. An international audience of opinion makers, business leaders, and global organizations recognize Ebeling as an expert.